US Stock MarketDetailed Quotes
CNTA Centessa Pharmaceuticals
- 8.790
- -0.250-2.77%
Close May 15 16:00 ET
- 8.620
- -0.170-1.93%
Post 17:40 ET
993.66MMarket Cap-6190P/E (TTM)
9.330High8.700Low182.74KVolume9.040Open9.040Pre Close1.61MTurnover0.32%Turnover RatioLossP/E (Static)113.04MShares12.45052wk High4.62P/B497.75MFloat Cap3.96052wk Low--Dividend TTM56.63MShs Float26.900Historical High--Div YieldTTM6.97%Amplitude2.885Historical Low8.836Avg Price1Lot Size
Centessa Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 22.06%-37.29M | 20.05%-160.34M | 39.78%-31.05M | 4.34%-37.39M | 26.41%-44.06M | 4.36%-47.84M | -200.55M | -51.56M | -39.09M | -59.88M |
| Net income from continuing operations | 24.98%-38.05M | 30.12%-151.09M | 14.68%-36.84M | 28.26%-38.65M | 61.51%-24.89M | 6.94%-50.71M | ---216.21M | ---43.17M | ---53.88M | ---64.66M |
| Depreciation and amortization | 169.66%240K | 518.32%810K | 583.33%246K | 580.00%238K | 640.63%237K | 217.86%89K | --131K | --36K | --35K | --32K |
| Deferred tax | --434K | -828.56%-26.53M | 94.63%-149K | -2,040.74%-2.89M | ---23.49M | --0 | ---2.86M | ---2.77M | ---135K | ---- |
| Other non cash items | ---- | -83.82%28K | ---67K | ---- | ---- | ---- | --173K | ---- | ---- | ---- |
| Change In working capital | -47.80%-9.17M | -566.13%-18.86M | 75.98%-3.37M | -162.97%-4.45M | -174.43%-4.84M | -164.52%-6.2M | ---2.83M | ---14.04M | --7.06M | --6.5M |
| -Change in receivables | -71.92%1.21M | -3.25%-12.09M | -105.36%-7.94M | 8.83%-2.32M | -1,534.81%-6.14M | 175.17%4.31M | ---11.71M | ---3.86M | ---2.55M | --428K |
| -Change in prepaid assets | 199.07%3.21M | 63.45%-1.36M | 123.26%1.85M | -174.32%-2.48M | -58.06%-1.81M | -46.67%1.07M | ---3.73M | ---7.94M | --3.34M | ---1.14M |
| -Change in payables and accrued expense | -17.97%-13.67M | -127.90%-3.52M | 217.52%2.63M | -96.33%230K | -27.83%5.2M | -946.09%-11.58M | --12.61M | ---2.24M | --6.27M | --7.21M |
| -Change in other current assets | --76K | ---1.88M | --85K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 22.06%-37.29M | 20.05%-160.34M | 39.78%-31.05M | 4.34%-37.39M | 26.41%-44.06M | 4.36%-47.84M | ---200.55M | ---51.56M | ---39.09M | ---59.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 119.41%16.76M | -13,541.68%-127M | -3,997.53%-18.28M | 304,512.50%48.71M | -30,947.60%-71.1M | -35,873.33%-86.34M | -931K | -446K | -16K | -229K |
| Net PPE purchase and sale | --0 | 85.14%-169K | 95.71%-28K | -168.75%-43K | 95.63%-10K | 63.33%-88K | ---1.14M | ---652K | ---16K | ---229K |
| Net investment purchase and sale | 119.43%16.76M | ---126.84M | ---18.25M | --48.75M | ---71.09M | ---86.25M | --0 | --0 | --0 | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | --206K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 119.41%16.76M | -13,541.68%-127M | -3,997.53%-18.28M | 304,512.50%48.71M | -30,947.60%-71.1M | -35,873.33%-86.34M | ---931K | ---446K | ---16K | ---229K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10.49M | 4,520.79%21.12M | 7,047.19%6.36M | 6,482.14%14.74M | -82.86%12K | 0 | 457K | 89K | 224K | 70K |
| Net common stock issuance | --9.66M | --20.81M | --6.24M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --838K | -56.82%310K | 32.58%118K | -19.64%180K | -82.86%12K | --0 | --718K | --89K | --224K | --70K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---261K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --10.49M | 4,520.79%21.12M | 7,047.19%6.36M | 6,482.14%14.74M | -82.86%12K | --0 | --457K | --89K | --224K | --70K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.48%128.03M | -33.85%393.64M | -61.45%171.5M | -70.01%145.22M | -52.25%259.99M | -33.85%393.64M | --595.08M | --444.84M | --484.16M | --544.47M |
| Current changes in cash | 92.52%-10.03M | -32.44%-266.23M | 17.25%-42.96M | 167.02%26.06M | -91.80%-115.15M | -167.37%-134.17M | ---201.02M | ---51.92M | ---38.88M | ---60.04M |
| Effect of exchange rate changes | -57.72%219K | 247.13%615K | -169.81%-504K | 150.23%220K | 242.16%381K | 219.35%518K | ---418K | --722K | ---438K | ---268K |
| End cash Position | -54.53%118.22M | -67.48%128.03M | -67.48%128.03M | -61.45%171.5M | -70.01%145.22M | -52.25%259.99M | --393.64M | --393.64M | --444.84M | --484.16M |
| Free cash flow | 22.20%-37.29M | 20.41%-160.51M | 40.48%-31.08M | 4.27%-37.44M | 26.68%-44.07M | 4.64%-47.93M | ---201.68M | ---52.22M | ---39.1M | ---60.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg